A randomized controlled study of segmental neuromyotherapy for post-stroke hemiplegic shoulder pain
DOI:
https://doi.org/10.2340/16501977-1021Keywords:
stroke, hemiplegia, shoulder pain, spinal sensitization.Abstract
Objective: To assess the effectiveness of segmental neuromyotherapy combined with standard hospital therapy relative to standard therapy alone in patients with hemiplegic shoulder pain. Design: Randomized controlled trial. Patients: A total of 24 patients with positive Neer?s and hand-behind-neck tests received standard therapy for shoulder pain. Half of them received additional segmental neuromyotherapy. Methods: Pain severity (visual analogue scale), upper-limb function (Fugl-Meyer arm score), and spasticity (Ashworth scale) were evaluated at 2 days (T1) and 1 day (T2) pre-treatment, in the middle (T3) and at the end (T4) of 4 weeks treatment, and 2 months post-treatment (T5). Results: The treatment group showed significant advantage compared with the Control group in Fugl-Meyer scores at T4 (p = 0. 014) and T5 (p = 0. 0078) compared with initial values. Significant advantage was also shown in the Neer?s test at T4 (p = 0. 014), with borderline significance at T5 (p = 0. 072). A larger decrease in pain scores reported by the treatment group at T5 (p = 0. 068) may have been biased by higher rates of spatial neglect in this group. Conclusion: Segmental neuromyotherapy added to standard therapy provides an advantage in pain relief and overall arm function in patients with hemiplegic shoulder pain.Downloads
Downloads
Published
How to Cite
Issue
Section
License
All digitalized JRM contents is available freely online. The Foundation for Rehabilitation Medicine owns the copyright for all material published until volume 40 (2008), as from volume 41 (2009) authors retain copyright to their work and as from volume 49 (2017) the journal has been published Open Access, under CC-BY-NC licences (unless otherwise specified). The CC-BY-NC licenses allow third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
From 2024, articles are published under the CC-BY licence. This license permits sharing, adapting, and using the material for any purpose, including commercial use, with the condition of providing full attribution to the original publication.